Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor
AUTOR(ES)
Lubkowski, Jacek
FONTE
National Academy of Sciences
RESUMO
The x-ray structures of an inhibitor complex of the catalytic core domain of avian sarcoma virus integrase (ASV IN) were solved at 1.9- to 2.0-Å resolution at two pH values, with and without Mn2+ cations. This inhibitor (Y-3), originally identified in a screen for inhibitors of the catalytic activity of HIV type 1 integrase (HIV-1 IN), was found in the present study to be active against ASV IN as well as HIV-1 IN. The Y-3 molecule is located in close proximity to the enzyme active site, interacts with the flexible loop, alters loop conformation, and affects the conformations of active site residues. As crystallized, a Y-3 molecule stacks against its symmetry-related mate. Preincubation of IN with metal cations does not prevent inhibition, and Y-3 binding does not prevent binding of divalent cations to IN. Three compounds chemically related to Y-3 also were investigated, but no binding was observed in the crystals. Our results identify the structural elements of the inhibitor that likely determine its binding properties.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=20173Documentos Relacionados
- Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design
- Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity
- Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein
- Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase.
- Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding
